Famous health and wellness platform, Hims & Hers Health, Inc. HIMS has established itself as a leading digital health and wellness platform to expand access to personalized, technology-enabled care. The company continues to expand its reach across all life stages and conditions, deepening its platform with new specialties and active health tools. Recent launches reflect this evolution. In women’s health, the Hers platform introduced a dedicated menopause and perimenopause feature, offering treatment plans specifically designed for women at different life stages. In Men’s Health, HIMS launches a new low testosterone category, which includes home testing and access to innovative oral and personalized treatment options supported by licensed providers.
At the same time, His & Hers is moving decisively toward proactive and data-driven care. The launch of Labs introduced comprehensive, in-depth testing designed to help customers monitor key health markers over time, paired with provider-guided action plans. Building on that momentum, HIMS recently launched access to a multi-cancer early detection blood test designed to screen for signs of more than 50 cancer types. Strategic investments in AI, diagnostics and global expansion further strengthen its ambition to build a connected, consumer-first healthcare platform that makes personalized, preventive care more accessible around the world.
Tempus AI, Inc. TEM is advancing precision medicine through an integrated, AI-enabled platform that connects genomics, multimodal data, and clinical workflows to deliver more personalized care. Tempus AI recently launched Page Predict, an AI-powered digital pathology solution that analyzes routine H&E slides to predict clinically actionable biomarkers and inform testing decisions.
Building on its RNA capabilities, TEM also introduced a new pan-cancer HRD-RNA algorithm, designed to identify patients most likely to benefit from targeted therapies. In parallel, Tempus AI expanded its Pixel platform by integrating AI-powered lung cancer screening to enhance early detection and risk stratification, strengthening Tempus AI’s role as a data-driven, AI-centric healthcare platform.
American Well Corporation AMWL, commonly known as Amwell, has positioned itself as a technology-enabled care infrastructure company focused on the Amwell platform, designed to consolidate digital health programs into an integrated, API-first ecosystem for payers, government and health systems. AMWL emphasizes hybrid care that combines automation, AI-powered workflows and physician oversight to reduce costs and improve outcomes, viewing technology-enabled care as essential rather than optional.
